1. Volume 125, Issue 1, Pages 32-39 (July 2003)
Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort study 
Severine Vermeire, Maja Noman, Gert Van Assche, Filip Baert, Kristel Van Steen, Nele Esters, Sofie Joossens, Xavier Bossuyt, Paul Rutgeerts 
Gastroenterology 
Volume 125, Issue 1, Pages (July 2003)
DOI: /S (03)

2. Figure 1
Cumulative incidence of ANA (% Y axis) over time (months X axis) in the total study cohort (n = 125). The number of patients who reached the respective follow up is given between brackets. M0 is prior to any infliximab treatment.
Gastroenterology  , 32-39DOI: ( /S (03) )

3. Figure 2
The relationship of ANA incidence (Y axis) with regard to the number of infliximab infusions (X axis) in the study cohort (n = 125).
Gastroenterology  , 32-39DOI: ( /S (03) )

4. Figure 3
Kinetics of ANA during the study follow up (n = 71). Prevalence of increasing, stable, and decreasing ANA antibodies are given (median follow-up for each group between brackets).
Gastroenterology  , 32-39DOI: ( /S (03) )